Biota

Company Overview

Snapshot

Founded in December 1999 by Meir Haber, Biota operates with 1–10 employees. The company specializes in bioadhesive technologies and products, holding a patent for its AlgiFilm filmstrips, which are designed for drug and nutritional supplement delivery.

Business overview

Biota is a highly specialized drug-delivery company focused on developing and commercializing bioadhesive technologies. Its core product, AlgiFilm, consists of proprietary oral mucoadhesive filmstrips that serve as a versatile and precise drug-delivery system. These filmstrips aim to improve patient compliance through conformable adherence and oral mucosa administration, offering features like taste-masking and enhanced bioavailability. The company also explores marine algae as a source for novel biomimetic adhesives, targeting the pharmaceuticals and biotechnology sectors within the healthcare and life sciences market.

Company Intelligence Q&A

What is Biota's primary product?

Biota's primary product is AlgiFilm, a proprietary oral mucoadhesive filmstrip technology designed for the precise delivery of pharmaceuticals and nutritional supplements.

When was Biota founded?

Biota was founded in December 1999.

Who is the founder of Biota?

Meir Haber is the founder and CEO of Biota.

What markets does Biota target?

Biota targets the United States and Israel with its drug and supplement delivery technologies.

What is the primary application of Biota's technology?

Biota's technology is primarily applied to developing simple-to-administer pharmaceuticals and nutritional supplements through its patented AlgiFilm filmstrips.